On Thursday’s “Ask Halftime,” traders answered questions from CNBC Pro subscribers about which stocks to buy, hold or sell right now. Jenny Harrington of Gilman Hill Asset Management discussed why she sold AT & T and will be looking to buy it back in the future. Cerity Partners’ Jim Lebenthal shared why he thinks Bristol-Myers Squibb is a good long-term hold.